Viewing Study NCT02830932


Ignite Creation Date: 2025-12-24 @ 9:32 PM
Ignite Modification Date: 2025-12-26 @ 11:17 PM
Study NCT ID: NCT02830932
Status: COMPLETED
Last Update Posted: 2018-08-16
First Post: 2016-03-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Dose-Ranging Trial of Safety & Immunogenicity of an Oral Adenoviral-Vector Based RSV Vaccine (VXA-RSV-f)
Sponsor: Vaxart
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module